glp-1 lilly FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - Eli Lilly to pour $6.5 billion
Pay in 4 interest-free payments of $5.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7









.jpg)















